Clinical Trial Update: S-1 in Combination With Abraxane in Treating Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating S-1 in combination with Abraxane for cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Yuhong Li | Conditions: Cholangiocarcinoma | Phase 2 | Status: COMPLETED